Sterne Kessler
  • Professionals
    View All Professionals
    A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Expertise
  • Sterne Kessler AI
Sterne Kessler AI
  • Professionals
  • Expertise
  • News & Insights
  • Events
  • About
  • Careers
  • Visit our Office
  • Subscribe
  • Contact

Insight: Articles

Resurgence of Stellarators and Impact on IP

Disclosing the Undisclosable: Section 112(a) Challenges for Artificial Intelligence Patents

Drafting Patent Applications That Travel the Atlantic – Tips for Companies Filing in the United States and Europe

Making Effective Use of DOD’s “Patent Holiday” Program

First Strike: Anonymous Reexamination as a Strategic Lever

Role of Inventors in Reexamination

How To Turn EU AI Act Disclosures Into Patent Assets

Overcoming § 101 in Medical Device Applications

2025 Federal Circuit IP Appeals: Data and Trends: IP Appeals to the Federal Circuit (USPTO, District Court, and ITC)

2025 Federal Circuit IP Appeals: Teva Branded Pharm. Prods. R&D, Inc. v. Amneal Pharms. of New York, LLC, 124 F.4th 898 (Fed. Cir. 2024) (Prost, Taranto, Hughes)

Posts navigation

Older posts
Newer posts

Recent Posts

    Recent Comments

    No comments to show.

    Archives

    No archives to show.

    Categories

    • No categories

    Sterne, Kessler, Goldstein & Fox PLLC

    1101 K Street NW, 10th Floor

    Washington, DC 20005
    (202) 371-2600
    • Professionals
    • Expertise
    • Contact
    • About
    • News & Insights
    • Subscribe
    • Careers
    • Visit our Office
    • Disclaimer
    • Privacy
    • Unsubscribe
    • Sitemap
    © 2026 Sterne, Kessler, Goldstein & Fox PLLC. Attorney advertising; prior results do not guarantee a similar outcome.
    Hit enter to search or ESC to close